Tag:
Prolensa
Latest Headlines
Latest Headlines
Hungry for ISTA, Valeant makes bid
Canada's Valeant Pharmaceuticals ( $VRX ) will push for at least one more acquisition before the holidays: U.S.-based rival ISTA Pharmaceuticals ($ISTA). The unsolicited bid for the California-based
ISTA one for two in a pair of Phase III eye drug studies
ISTA Pharmaceuticals says it snagged the late-stage data it needs to win an approval for Prolensa, which relies on a low concentration of bromfenac to treat pain and inflammation caused by cataract
